Skip to main content

Published locations for Extension study finds dupilumab effective for up to 1 year in teens with AD

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Extension study finds dupilumab effective for up to 1 year in teens with AD

User login

  • Reset your password
  • /content/extension-study-finds-dupilumab-effective-1-year-teens-ad
  • /edermatologynews/article/247021/atopic-dermatitis/extension-study-finds-dupilumab-effective-1-year
  • /familypracticenews/article/247021/atopic-dermatitis/extension-study-finds-dupilumab-effective-1-year
  • /pediatricnews/article/247021/atopic-dermatitis/extension-study-finds-dupilumab-effective-1-year
  • /pediatrics/article/247021/atopic-dermatitis/extension-study-finds-dupilumab-effective-1-year-teens
  • /dermatology/article/247021/atopic-dermatitis/extension-study-finds-dupilumab-effective-1-year-teens
  • /familymedicine/article/247021/atopic-dermatitis/extension-study-finds-dupilumab-effective-1-year